Get the latest industry insights.

Quality people. Great service. Responsive. Professional.

Day: September 1, 2020

AstraZeneca Expands Phase III

AstraZeneca Expands Phase III COVID-19 Vaccine Trial into the U.S.

Via: AstraZeneca announced that its Phase III clinical trial of its COVID-19 vaccine  candidate, AZD1222, is expanding into the U.S. It will be dubbed D8110C00001 and is funded by the Biomedical Advanced Development Authority (BARDA) and the National Institute of Allergy and Infectious Diseases (NIAID). The

Read More »